These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27981626)

  • 1. Regression of Nevi After Candida Injection for the Treatment of Verruca Vulgaris.
    Kollmann E; Cleaver D; Cleaver L; Cleaver J
    Pediatr Dermatol; 2017 Mar; 34(2):199-200. PubMed ID: 27981626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphangitis occurring after intralesional Candida antigen injection for verruca vulgaris.
    Zubritsky L; Alikhan A
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.
    Summers P; Richards-Altmon P; Halder R
    J Drugs Dermatol; 2009 Mar; 8(3):268-9. PubMed ID: 19271374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis Following Treatment of Verruca Vulgaris with Intralesional
    Crowley NJ; Hagan JC; Dyer JA; Brundige TF
    Mo Med; 2017; 114(5):394-395. PubMed ID: 30228642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
    Johnson SM; Roberson PK; Horn TD
    Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children.
    Muñoz Garza FZ; Roé Crespo E; Torres Pradilla M; Aguilera Peirò P; Baltà Cruz S; Hernández Ruiz ME; Baselga Torres E
    Pediatr Dermatol; 2015; 32(6):797-801. PubMed ID: 26584692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
    Horn TD; Johnson SM; Helm RM; Roberson PK
    Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Candida antigen injections for the treatment of verruca vulgaris: A two-year mayo clinic experience.
    Alikhan A; Griffin JR; Newman CC
    J Dermatolog Treat; 2016 Aug; 27(4):355-8. PubMed ID: 26558635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of intralesional Candida vaccine versus topical diphencyproprobenone in immunotherapy of verruca vulgaris: A randomized comparative study.
    El-Komy MHM; Shamma SG; Bedair NI
    Arch Dermatol Res; 2023 Apr; 315(3):583-591. PubMed ID: 36245011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
    Fathy G; Sharara MA; Khafagy AH
    Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
    Clifton MM; Johnson SM; Roberson PK; Kincannon J; Horn TD
    Pediatr Dermatol; 2003; 20(3):268-71. PubMed ID: 12787281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood toll-like receptor 4 correlates response to candida immunotherapy of warts.
    Sabry HH; Hamed AM; Salem RM; Marei AM; El Sebaey RM
    Dermatol Ther; 2018 Sep; 31(5):e12691. PubMed ID: 30226014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional immunotherapy compared to cryotherapy in the treatment of warts.
    Khozeimeh F; Jabbari Azad F; Mahboubi Oskouei Y; Jafari M; Tehranian S; Alizadehsani R; Layegh P
    Int J Dermatol; 2017 Apr; 56(4):474-478. PubMed ID: 28108992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
    Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
    Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts.
    Nofal A; Yehia E; Khater E; Bessar H
    J Am Acad Dermatol; 2020 Jul; 83(1):208-210. PubMed ID: 32006600
    [No Abstract]   [Full Text] [Related]  

  • 18. Intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosum in children.
    Enns LL; Evans MS
    Pediatr Dermatol; 2011; 28(3):254-8. PubMed ID: 21615471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional Candida antigen for common warts in people with HIV.
    Wong A; Crawford RI
    J Cutan Med Surg; 2013; 17(5):313-5. PubMed ID: 24067850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial.
    Saoji V; Lade NR; Gadegone R; Bhat A
    Indian J Dermatol Venereol Leprol; 2016; 82(1):42-6. PubMed ID: 26728809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.